It has been shown that the androgen signaling pathway plays an important role in prostate cancer progression even at the CRPC stage, and inhibition of the androgen receptor pathway signaling can improve the antitumor efficacy of chemotherapeutic drugs against CRPC [30]. Here, AR is linked to prostate carcinoma.